GRANULES CONSUMER HEALTH — Guaifenesin Importer Profile
Pharmaceutical Importer · #1 buyer for Guaifenesin · $4.5M import value · 121 shipments · UNITED STATES · DGFT Verified
GRANULES CONSUMER HEALTH is the #1 importer of Guaifenesin from India with $4.5M in import value and 121 verified shipments. GRANULES CONSUMER HEALTH holds a 21.7% market share in Guaifenesin imports based in UNITED STATES. The company sources from 1 verified supplier across 59 formulations shipped to 2 countries. Overall, GRANULES CONSUMER HEALTH imports 8 pharmaceutical products worth $110.4M across 4 therapeutic categories.
GRANULES CONSUMER HEALTH — Guaifenesin Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Guaifenesin to GRANULES CONSUMER HEALTH?
Verified from 121 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| GRANULES INDIA LIMITED | $4.5M | 121 | 100.0% |
GRANULES CONSUMER HEALTH sources Guaifenesin from 1 verified Indian supplier based on 121 customs records. The primary supplier is GRANULES INDIA LIMITED accounting for 100.0% of imports.
How Does GRANULES CONSUMER HEALTH Compare to Nearest Guaifenesin Importers?
Buyers ranked immediately above and below #1 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 1 | GRANULES CONSUMER HEALTH ★ | UNITED STATES | $5.8M | 116 | $50.0K |
| 2 | SPIRIT PHARMACEUTICALS LLC | UNITED STATES | $1.8M | 36 | $50.0K |
| 4 | GRANULES USA INC. | UNITED STATES | $905.1K | 25 | $36.2K |
GRANULES CONSUMER HEALTH ranks #1 among 278 Guaifenesin importers from India. Average shipment value of $50.0K compared to the market average of $52.3K. The closest competitors by value are SPIRIT PHARMACEUTICALS LLC and GRANULES USA INC..
Where Does GRANULES CONSUMER HEALTH Import Guaifenesin To?
Destination countries from 121 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $4.5M | 120 | 98.9% |
| UNITED STATES OF AMERICA | $50.0K | 1 | 1.1% |
GRANULES CONSUMER HEALTH imports Guaifenesin to 2 countries. The primary destination is UNITED STATES receiving 98.9% of shipments worth $4.5M.
What Guaifenesin Formulations Does GRANULES CONSUMER HEALTH Import?
| Formulation | Value | Shipments |
|---|---|---|
| GUAIFENESIN EXTENDED RELEASE TABLETS 600 | $360.2K | 10 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 600MG | $359.1K | 9 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG-14'S | $300.0K | 6 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 120 | $200.0K | 4 |
| GUAIFENESIN EXTENDED-RELEASE TABLETS 600MGNOS | $154.7K | 6 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG-14S(201,000.000PAC) | $150.0K | 3 |
| GUAIFENESIN EXTENDED-RELEASE TABLETS 1200MGNOS | $148.8K | 3 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 1200MGNOS | $148.1K | 3 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 1200MG/GUSA(2,860.000PAC) | $147.1K | 3 |
| GUAIFENESIN EXTENDED RELEASE TABLETS 600MG 500#S(9336.000PAC)NOS | $132.5K | 3 |
GRANULES CONSUMER HEALTH imports 59 distinct Guaifenesin formulations from India. The top formulation is GUAIFENESIN EXTENDED RELEASE TABLETS 600 with 10 shipments worth $360.2K.
Regulatory Requirements: Importing Guaifenesin into United States
What GRANULES CONSUMER HEALTH and other importers must comply with to import Guaifenesin from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Guaifenesin
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Guaifenesin from India and How Much Does GRANULES CONSUMER HEALTH Import?
India exported $14.5M worth of Guaifenesin through 1,050 shipments from 151 suppliers to 77 countries, serving 278 buyers globally. GRANULES CONSUMER HEALTH imports $4.5M of this total, accounting for 21.7% of India's Guaifenesin exports with 121 shipments from UNITED STATES. This is verified from 121 customs shipment records covering 59 distinct formulations.
What Is the Average Order Value for GRANULES CONSUMER HEALTH's Guaifenesin Imports?
GRANULES CONSUMER HEALTH's average Guaifenesin order value is $37.6K per consignment, based on 121 shipments totaling $4.5M. GRANULES CONSUMER HEALTH is based in UNITED STATES and ranks #1 among all Guaifenesin importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Guaifenesin to GRANULES CONSUMER HEALTH?
GRANULES CONSUMER HEALTH sources Guaifenesin from 1 verified Indian supplier: GRANULES INDIA LIMITED ($4.5M, 100.0%). This is based on 121 customs records.
How Does GRANULES CONSUMER HEALTH Compare to Other Guaifenesin Importers?
GRANULES CONSUMER HEALTH ranks #1 among 278 Guaifenesin importers from India with a 21.7% market share. The top 3 importers are GRANULES CONSUMER HEALTH ($5.8M), SPIRIT PHARMACEUTICALS LLC ($1.8M), GRANULES USA INC. ($905.1K). GRANULES CONSUMER HEALTH processed 121 shipments from UNITED STATES.
About GRANULES CONSUMER HEALTH
GRANULES CONSUMER HEALTH imports 8 products worth $110.4M. Beyond Guaifenesin, top products include Acetaminophen, Amino, Fexofenadine, Cetirizine, Loratadine. View the complete GRANULES CONSUMER HEALTH profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Guaifenesin — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Guaifenesin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: GRANULES CONSUMER HEALTH matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as GRANULES CONSUMER HEALTH's capped import value divided by total capped export value for Guaifenesin across all Indian exporters.
- 5.Verified Records: This page is backed by 121 individual customs records matching GRANULES CONSUMER HEALTH importing Guaifenesin, covering 59 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 77+ countries, 278+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Guaifenesin Import Data for GRANULES CONSUMER HEALTH
Access order-level details, pricing data, supplier connections, and competitive analysis for GRANULES CONSUMER HEALTH's Guaifenesin imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
GRANULES CONSUMER HEALTH
Full Company Profile →
8 products · $110.4M total trade · 4 categories
GRANULES CONSUMER HEALTH × Guaifenesin
Verified from customs records
Company Overview
Top Products by GRANULES CONSUMER HEALTH
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for GRANULES CONSUMER HEALTH.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Guaifenesin. For current order-level data, contact TransData Nexus.